HTLV-I infection and the low prevalence of Helicobacter pylori infection in Japan [comment] NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HTLV-I infection and the low prevalence of Helicobacter pylori infection in Japan [comment]

Eur J Gastroenterol Hepatol. 1999 May;11(5):481-3. Unique Identifier : AIDSLINE MED/20216025
Walker M; Department of Histopathology, Imperial College School of Medicine; at St Mary's, London. mm.walker@ic.ac.uk


Abstract: HTLV-I retrovirus infection and Helicobacter pylori infection are common in Japan; however a report in this issue shows a significantly low prevalence of H. pylori in patients infected with HTLV-I. The reasons for this may be due to differences in genetic susceptibility of the infections, the gastric milieu in HTLV-I being unable to support H. pylori, or because antimicrobial therapy in HTLV-I infection has eradicated H. pylori in this susceptible population. Similarities between HIV-1, another retroviral infection, and the prevalence of H. pylori are noted.


Keywords: COMMENT JOURNAL ARTICLE Comorbidity Genetic Predisposition to Disease *Helicobacter pylori Helicobacter Infections/*EPIDEMIOLOGY/GENETICS Human HTLV-I Infections/*EPIDEMIOLOGY/GENETICS Japan/EPIDEMIOLOGY PrevalenceKWDcommentjournalarticlecomorbiditygeneticpredispositiontodiseaseKWDhelicobacterpylorihelicobacterinfections/KWDepidemiology/geneticshumanhtlv-iinfections/KWDepidemiology/geneticsjapan/epidemiologyprevalence
Comment on: Eur J Gastroenterol Hepatol 1999 May;11(5):497-502
000730
A0071454

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .